Ownership

Based in the greater St. Louis area, privately held Fleming Pharmaceuticals specializes in the discovery, development, and manufacture of innovative prescription and over-the-counter (OTC) therapies. Established in 1960, the company has developed products for a variety of clinical conditions in allergy, pediatrics, nephrology, nutrition, and obstetrics/gynecology. Our fully integrated headquarter facility houses state-of-the-art liquid and solid pharmaceutical manufacturing and packaging, analytical microbiological laboratories, research and development, distribution, marketing, and business administration functions.

Management

Having launched many proprietary and OTC products, Fleming’s senior management team fosters a progressive entrepreneurial culture, which honors the legacy of founder Tom Fleming while aggressively positioning the company for expansion.

Owned and operated by Deborah Fleming Wurdack and her sister Tommye Fleming, the company is led by a management team with extensive experience in the pharmaceutical industry, life sciences, and financial management. Fleming’s Board of Directors guides the senior management team in developing strategic initiatives such as licensing opportunities and business partnerships.

Founder and history

With a Master’s degree in chemistry from St. Louis University, Tom Fleming founded the pharmaceutical company that bears his name in 1960. For more than four decades, Mr. Fleming’s scientific prowess complemented his unique ability to envision and develop new products based on his discussions with physicians. Well known nationally in the medical community, Mr. Fleming remained active in the daily management of the company until his death in 2003. Today second- and third-generation family members at the company carry on the founder’s legacy of innovation and uncompromising standards in pharmaceuticals research and development, manufacturing, and sales.

Mr. Fleming’s scientific rigor, insistence on the highest standards, and special relationship with the healthcare community endure today as pillars of Fleming's heritage. Fleming products are manufactured with pride under exacting quality standards in state-of-the-art laboratory facilities in St. Louis County, Missouri.

(click here for full bio)

President

Phillip Dritsas

Pharmaceutical industry veteran Phillip Dritsas is President of Fleming Pharmaceuticals. As president, Mr. Dritsas’ main responsibility is to lead new corporate and product strategy, prepare for pending approval of new products in clinical development with the U.S. Food and Drug Administration, and dramatically expand the company’s marketing and selling capabilities.

Mr. Dritsas is in prime position to lead Fleming to its next stage of development. During his more than two decades in the pharmaceutical industry, Mr. Dritsas launched major brands and generic entries, prescription as well as over-the-counter, and helped grow his former company from sales of a few million to a notable pharmaceutical company.
(click here for full bio)

Executive team

Fleming Executive Team

Deborah Fleming Wurdack

Co-owner and Chief Administrative Officer

As daughter of company founder Tom Fleming, Deborah Fleming Wurdack literally grew up in the pharmaceutical industry. She has worked in all areas of Fleming, from business administration, to manufacturing and distribution, to product development and marketing.

(click here for full bio) 

Thomas Mengwasser

Chief Financial Officer

Thomas Mengwasser is Chief Financial Officer of Fleming Pharmaceuticals. He is responsible for directing the company’s overall financial activities, including accounting, finance, treasury and tax, since joining the Company in 2004. Mr. Mengwasser also oversees Fleming’s information systems. 

(click here for full bio) 

Scott Sims
Vice President, Marketing and Sales

Scott Sims, Vice President of Marketing and Sales for Fleming Pharmaceuticals has been a sales and marketing leader in the pharmaceutical industry for 15 years, with experience in building commercial teams, strategic and financial planning and implementation, and opinion leader development. Mr. Sims’ main duty at Fleming is to lead sales and marketing initiatives to build on current consumer and prescription brands while finding new opportunities through business development collaboration.

(click here for full bio) 

Jennifer Thaxton
Vice President, Operations

As Vice President of Operations for Fleming Pharmaceuticals, Jennifer Thaxton supervises materials management, manufacturing, facility maintenance, and shipping and receiving. She also collaborates with the company’s sales and marketing departments in the development and manufacturing of new products.

(click here for full bio) 

George Love
General Counsel/Vice President, Legal & Regulatory Affairs

As General Counsel/Vice President  of Legal & Regulatory Affairs for Fleming Pharmaceuticals, George Love manages all of the company’s legal and regulatory activities, as well as the Company’s Laboratory Services and quality assurance departments. As Fleming’s in-house legal counsel, Mr. Love is responsible for all aspects of the organization’s legal work, including commercial contracts, intellectual property, litigation and more. He is actively involved in establishing and implementing the company’s product and regulatory development strategies, and is a member of the company’s executive management committee.

(click here for full bio)

Mission and Purpose

Fleming is a specialty pharmaceutical company focused on growth through the development and acquisition of innovative prescription and OTC products. Our company creates value for our customers, employees, and shareholders with a deep commitment to quality. We seek opportunities in domestic and international markets and are guided by the needs of our customers. Fleming offers a rewarding and entrepreneurial work environment where tradition, integrity, and diversity are valued and where people are heard, challenged, and given opportunities for growth.

Fleming Corporate Quality Policy

Corporate Compliance Program Description